| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 122.59B | 119.76B | 115.22B | 114.88B | 117.11B | 77.33B |
| Gross Profit | 26.90B | 25.25B | 21.94B | 24.45B | 32.23B | 16.14B |
| EBITDA | 18.72B | 17.00B | 14.46B | 16.01B | 24.19B | 9.48B |
| Net Income | 8.99B | 8.36B | 6.83B | 8.07B | 13.69B | 4.05B |
Balance Sheet | ||||||
| Total Assets | 125.88B | 131.46B | 124.50B | 131.25B | 122.07B | 95.51B |
| Cash, Cash Equivalents and Short-Term Investments | 5.40B | 7.16B | 9.68B | 10.93B | 16.93B | 9.07B |
| Total Debt | 20.63B | 19.20B | 16.39B | 22.52B | 20.16B | 21.46B |
| Total Liabilities | 55.23B | 59.54B | 58.01B | 69.18B | 64.57B | 49.63B |
| Stockholders Equity | 67.80B | 69.09B | 63.74B | 59.35B | 54.92B | 43.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.45B | 7.94B | -5.36B | 13.00B | -4.20B |
| Operating Cash Flow | 0.00 | 6.98B | 13.20B | 5.13B | 17.40B | 6.93B |
| Investing Cash Flow | 0.00 | -8.90B | -4.94B | -10.08B | -4.39B | -11.18B |
| Financing Cash Flow | 0.00 | -645.00M | -9.50B | -1.08B | -5.17B | -4.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥62.99B | 12.92 | ― | 2.88% | 3.42% | 13.37% | |
77 Outperform | ¥77.84B | 9.67 | ― | 3.06% | 2.02% | 30.10% | |
77 Outperform | ¥39.30B | 8.16 | ― | 3.53% | -3.45% | 30.52% | |
76 Outperform | ¥226.62B | 17.58 | ― | 1.23% | 8.80% | 33.39% | |
74 Outperform | ¥204.93B | 13.04 | ― | 4.09% | 1.69% | 0.94% | |
64 Neutral | ¥90.78B | 9.82 | ― | 3.88% | 2.61% | 30.29% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
KH Neochem Co., Ltd. reported its consolidated financial results for the nine months ending September 30, 2025, showing a slight decrease in net sales by 0.2% compared to the previous year. However, the company experienced significant growth in operating income, ordinary income, and net income attributable to owners of the parent, with increases of 16.2%, 15.0%, and 14.3% respectively. The company’s comprehensive income also rose by 17.2%. These results indicate a strong operational performance despite a slight dip in sales, suggesting an effective cost management strategy and operational efficiency.
The most recent analyst rating on (JP:4189) stock is a Buy with a Yen3031.00 price target. To see the full list of analyst forecasts on KH Neochem Co.,Ltd. stock, see the JP:4189 Stock Forecast page.